Hyderabad, February 25 ZeroHarm Sciences, a nano-formulated, plant-based nutraceutical brand, announced on Wednesday that it has raised ₹65 crore from Kotak Life Sciences Fund and Alkemi Growth Capital.Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I...
alkemi growth capital
consumer wellness
diagnostic testing
health platform
healthcare
hyderabad
india
investment funding
kotak life sciences fund
manufacturing
nanotechnology
nutraceuticals
plant-based supplements
r&d (research and development)
zeroharm sciences